Clarifying On-Target p38 Inhibition and Protein Restriction Effects in CKD-Associated Vascular Calcification

We read with great interest the recent study by Jin et al., published in JASN, combining 5/6 nephrectomy with a high-phosphate/low-protein diet to reproduce medial arterial and cutaneous arteriolar calcification and implicate p38 MAPK as a tractable target.1 The rapid, reproducible phenotype and the integration of histology, μCT, and transcriptomics are commendable and create a valuable platform for mechanistic and translational work. However, several methodologic considerations should be addressed to better contextualize the conclusions. First, pharmacologic specificity should be strengthened. Although SB203580 is widely used, it primarily inhibits p38α/β, with limited inhibition of p38γ/δ, and shows relevant off-target kinase inhibition at experimental concentrations.2 We therefore suggest replacing SB203580 with chemically distinct p38 inhibitors (e.g., BIRB-796 [doramapimod], GW856553 [losmapimod], and PH-797804) to test whether the phenotype is reproducible. Given that p38α (Mapk14) is predominant in vascular smooth muscle and its knockdown limits phosphate-induced calcification, we suggest a smooth-muscle–specific, tamoxifen-inducible p38α knockout (SM22α-CreERT2; Mapk14fl/fl) subjected to HPi–Lp+5/6 Nx for genetic validation. Second, the hypothesized synergy whereby malnutrition and hyperphosphatemia amplify calcification has not been directly tested. The authors note that malnutrition may indirectly promote vascular calcification by reducing calcification inhibitors (fetuin-A and matrix Gla protein).3 However, only aortic fetuin-A/matrix Gla protein has been measured without diet-stratified serum trajectories. We recommend an isocaloric pair-feeding or essential amino acid repletion to isolate protein effects from energy deficit. Moreover, we suggest serial measurement of serum fetuin-A and the calcium–phosphate product (Ca×P) during the induction phase, aligned with quantitative readouts of vascular calcium, to clarify how changes in circulating inhibitors and mineral balance track with tissue mineral deposition. Also, an exogenous fetuin-A supplementation (rescue) experiment would directly test the reversibility of the malnutrition–fetuin-A axis in a high-phosphate milieu. Third, generalizability is limited by the use of only male C57BL/6J mice and a short, 4-week exposure that did not reproduce characteristic skin necrosis/pain. Because sex modifies mineral metabolism and vascular remodeling, inclusion of females and longer follow-up would enhance translational relevance.4 In conclusion, the HPi–Lp 5/6 nephrectomy model offers a practical platform for mechanistic investigation and preclinical testing. Clarifying the independent contribution of protein restriction and rigorously establishing p38 as the causal effector would firmly strengthen translational relevance.